Skip to content
Carmelics
TopicsThinkersChangesContributorsLoading account…

    Carmelics

    A reasoning platform. Break down any belief into clear reasons, explore both sides, and weigh the evidence honestly.

    Navigate

    • Topics
    • Search
    • Recent Changes
    • Contribute
    • How It Works
    • Glossary
    • Thinkers
    • Contributors
    • About
    • Statistics
    • Terms
    • Privacy

    Database

    Statements
    —
    Perspectives
    —
    Topics
    —

    Press ? for keyboard shortcuts

    LoyalLoyalJusticeJustice
    Made withinDC&Austin
    Statements
    321,452
    Perspectives
    108,905
    Topics
    42
    Genetic vaccines that provide better-than-normal damage r... — Carmelics
    Home/Bioethics
    HistoryEditSee Inverse

    Genetic vaccines that provide better-than-normal damage resistance are permissible as treatments, not enhancements, if they target predictable muscle damage

    Bioethics
    ?Rate how convincing each reason is below to see the overall strength.
    1 reason for
    2 reasons against

    Reasons For

    1 perspective
    Reason for
    ?
    • 1.An intervention is legitimate treatment if it addresses a diagnosable malady
      ?

      Think about whether this reason is strong or weak

    • 2.Predictable muscle damage constitutes a diagnosable risk
      ?

      Think about whether this reason is strong or weak

    • 3.Intervening against a diagnosable risk qualifies as treatment even if the intervention incidentally produces above-normal capability
      ?

      Think about whether this reason is strong or weak

    Reasons Against

    2 perspectives
    Reason against 1 of 2
    ?
    • 1.The treatment/enhancement distinction requires a baseline of species-typical functioning, not merely the absence of a diagnosable malady (Boorse, Daniels).
      ?

      Think about whether this reason is strong or weak

    • 2.Interventions producing above-normal capability exceed species-typical functioning by definition, regardless of whether a risk condition was identified prior to intervention.
      ?

      Think about whether this reason is strong or weak

    • 3.Therefore, producing better-than-normal damage resistance cannot be classified as treatment even when targeting a predictable pathological risk.
      ?

      Think about whether this reason is strong or weak

    Reason against 2 of 2
    ?
    • 1.Classifying an intervention by its target rather than its outcome allows any enhancement to be reframed as treatment by identifying a pre-existing vulnerability it addresses (the 'bootstrapping' objection, Juengst 1997).
      ?

      Think about whether this reason is strong or weak

    • 2.A principled treatment/enhancement boundary must be outcome-sensitive, not merely intention- or target-sensitive, to avoid collapsing the distinction entirely.
      ?

      Think about whether this reason is strong or weak

    Sign in or register to share your perspective on this statement.

    Next step

    Based on where you are in your exploration

    Strongest counterpoint
    Explore the most compelling reason on the other side.

    Topics

    Bioethics

    Related

    A principled treatment/enhancement boundary must be outcome-sensitive, not merel...An intervention is legitimate treatment if it addresses a diagnosable maladyClassifying an intervention by its target rather than its outcome allows any enh...Intervening against a diagnosable risk qualifies as treatment even if the interv...
    +4 moreShow less
    Interventions producing above-normal capability exceed species-typical functioni...Predictable muscle damage constitutes a diagnosable riskThe treatment/enhancement distinction requires a baseline of species-typical fun...Therefore, producing better-than-normal damage resistance cannot be classified a...

    Similar

    Intervening against a diagnosable risk qualifies as treatment even if ...69%Predictable muscle damage constitutes a diagnosable risk69%The reciprocity argument for differential vaccination burdens has limi...68%Prescribing biosynthetic growth hormone to patients with normal growth...67%

    Source

    AI-extracted1/3 agreementValid
    SEP: enhancement
    View source passageHide passage
    Probably the most common rejoinder to the problem of prevention is to distinguish the problems to which they respond. Treatments are interventions that address the health problems created by diagnosable diseases and disabilities—“maladies” in the helpful language of Gert, Culver and Clouser (2006). Enhancements, on the other hand, are interventions aimed at healthy systems and traits. Thus, prescribing biosynthetic growth hormone to rectify a diagnosable growth hormone deficiency is legitimate t
    Extraction notes

    Validity: Extracted via Max plan + API grounding/validity checks

    Details

    Type
    claim
    Perspectives
    3 (1 for, 2 against)
    Edits
    1 edit